Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Consequences of Stat6 deletion on Sis/PDGF- and IL-4-induced proliferation and transcriptional activation in murine fibroblasts

Abstract

Aberrant communication among growth factors and cytokines that regulate tissue homeostasis often results in malignancy. Among the many cell types that participate in this process, stromal fibroblasts communicate in a paracrine and juxtracrine manner with cells of epithelial, endothelial, and hematopoietic origin. For fibroblasts, platelet-derived growth factor (PDGF) is a major proliferative and differentiation agent. Interleukin-4 (IL-4), however, possesses only modulating functions in this cell type. Here, we investigated the consequences of deleting Stat6 on PDGF and IL-4 signaling, proliferation, and transcriptional activation by establishing and characterizing early passage fibroblasts from wild-type and Stat6 null mice. Both wild-type and Stat6−/− fibroblasts showed nearly identical PDGFR and IL-4R activation, gross substrate tyrosine phosphorylation, PI 3-kinase activation, as well as Stat1, 3 and 5 DNA binding activities. Unexpectedly, IL-4's enhancement of PDGF-induced [3H]thymidine incorporation was greatly diminished in Stat6−/−, but not wild-type fibroblasts. PDGF-induced [3H]thymidine uptake was largely unaffected. Strikingly, IL-4, but not PDGF induction of the proinflammatory gene products, IL-6 and MCP-1 was markedly reduced in Stat6−/− fibroblasts. Thus, Stat6 is an important and specific mediator of IL-4-enhanced PDGF-induced proliferation as well as IL-4's transcriptional activation of IL-6 and MCP-1.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Aaronson SA. . 1991 Science 254: 1146–1153.

  • Ataliotis P and Mercola M. . 1997 Int. Rev. Cytol. 172: 95–127.

  • Barone MV and Courtneidge SA. . 1995 Nature 378: 509–512.

  • Betsholtz C and Raines EW. . 1997 Kidney Int. 51: 1361–1369.

  • Claesson-Welsh L. . 1996 Int. J. Biochem. Cell Biol. 28: 373–385.

  • Conrad DH, Waldschmidt T, Lee WT, Rao M, Keegan AD, Noelle RJ, Lynch RG and Kehry MR. . 1987 J. Immunol. 139: 2290–2296.

  • Danial NN, Pernis A and Rothman P. . 1995 Science 269: 1875–1877.

  • Devare SG, Reddy EP, Law DJ, Robbins KC and Aaronson SA. . 1983 Proc. Natl. Acad. Sci. USA 80: 731–735.

  • Dirks RPH and Bloemers HPJ. . 1996 Mol. Biol. Reports 22: 1–24.

  • Doolittle RF, Hunkapiller MW, Hood LE, Devare SG, Robbins KC, Aaronson SA and Antoniades HM. . 1983 Science 221: 275–277.

  • Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Canonica GW, Jasmin C and Azzarone B. . 1998 J. Clin. Invest. 101: 2129–2139.

  • Feghali CA, Bost KL, Boulware DW and Levy LS. . 1992 Clin. Immun. Immunopath. 63: 182–187.

  • Fleming TP, Matsui T, Heidaran MA, Molloy CJ, Artrip J and Aaronson SA. . 1992 Cancer Res. 52: 4550–4553.

  • Freter RR, Alberta JA, Hwang GY, Wrentmore AL and Stiles CD. . 1996 J. Biol. Chem. 271: 17417–17424.

  • Garcia R and Jove R. . 1998 J. Biomed. Sci. 5: 79–85.

  • Gay S, Jones RE, Guo-qiang H and Gay RE. . 1989 J. Invest. Dermatol. 92: 301–303.

  • Hall DJ, Jones SD, Kaplan DR, Whitman M, Rollins BJ and Stiles CD. . 1989 Mol. Cell. Biol. 9: 1705–1713.

  • Heldin C-H and Westermark B. . 1991 Crit. Rev. Oncog. 2: 109–124.

  • Honda M, Yamamoto S, Cheng M, Yasukawa K, Suzuki H, Saito H, Ohsugi Y, Tokunaga T and Kishimoto T. . 1992 J. Immunol. 148: 2175–2180.

  • Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M and McKnight SL. . 1994 Science 165: 1701–1706.

  • Ikebuchi K, Wong GC, Clark SC, Ihle JN, Hirai Y and Ogawa M. . 1987 Proc. Natl. Acad. Sci. USA 84: 9035–9039.

  • Ilaria RL and Van Etten RA. . 1996 J. Biol. Chem. 271: 31704–31710.

  • Jensen RA, Beeler J, Heidaran MA and LaRochelle WJ. . 1992 Biochemistry 31: 10887–10892.

  • Johnston JA, Kawamura M, Kirken RA, Chen YQ, Blake TB, Shibuya K, Ortaldo JR, McVicar DW and O'Shea JJ. . 1994 Nature 370: 151–153.

  • Kaplan MH, Schindler U, Smiley ST and Grusby MJ. . 1996 Immunity 4: 1–20.

  • Kotanides H and Reich NC. . 1993 Science 262: 1265–1267.

  • Kotanides H and Reich NC. . 1996 J. Biol. Chem. 271: 25555–25561.

  • Kundra V, Escobedo JA, Kazlauskas A, Kim HK, Rhee SG, Willaims LT and Zetter BR. . 1994 Nature 367: 474–476.

  • Kuperman D, Schofield B, Wills-Karp M and Grusby MJ. . 1998 J. Exp. Med. 187: 939–948.

  • LaRochelle WJ, Robbins KC and Aaronson SA. . 1989 Mol. Cell. Biol. 9: 3538–3542.

  • Leek RD, Harris AL and Lewis CE. . 1994 J. Leukoc. Biol. 56: 423–435.

  • Needleman BW, Wigley FM and Stair RW. . 1991 Arthritis Rheum. 35: 67–72.

  • Nelson SA and LaRochelle WJ. . 1999 In: Peters GA and Peters BJ. (eds). Sourcebook on Asbestos Diseases, Vol. 19. LEXIS Publishing: Charlottesville, VA pp. 291–325.

    Google Scholar 

  • Noelle R, Krammer PH, Ohara J, Uhr JW and Vitetta ES. . 1984 Proc. Natl. Acad. Sci. USA 81: 6149–6153.

  • Novak U, Mui A, Miyajima A and Paradiso L. . 1996 J. Biol. Chem. 271: 18350–18354.

  • Ohara J and Paul WE. . 1988 Proc. Natl. Acad. Sci. USA 85: 8221–8225.

  • Olashaw NE, Kowalik TF, Huang E-S and Pledger WJ. . 1992 Mol. Biol. Cell 3: 1131–1139.

  • Owen AJ, Geyer RP and Antoniades HN. . 1982 Proc. Natl. Acad. Sci. USA 79: 3203–3207.

  • Paquet P and Pierard GE. . 1996 Int. Arch. Allergy Immunol. 109: 308–317.

  • Patel BKR, Keck CL, O'Leary RS, Popescu NC and LaRochelle WJ. . 1998a Genomics 52: 192–200.

  • Patel BKR, Pierce JH and LaRochelle WJ. . 1998b Proc. Natl. Acad. Sci. USA 95: 172–177.

  • Patel BKR, Wang LM, Lee CC, Taylor WG, Pierce JH and LaRochelle WJ. . 1996 J. Biol. Chem. 21: 22175–22182.

  • Paul WE. . 1997 Ciba Found. Symp. 204: 208–216.

  • Peden K, Hurko O and Tennekoon G. . 1987 Prog. Clin. Biol. Res. 253: 101–109.

  • Postlethwaite AE, Holness MA, Katai H and Raghow R. . 1992 J. Clin. Invest. 90: 1479–1485.

  • Postlethwaite AE and Seyer JM. . 1991 J. Clin. Invest. 87: 2147–2152.

  • Quelle FW, Shimoda K, Thierfelder W, Fischer C, Kim A, Ruben SM, Cleveland JL, Pierce JH, Keegan AD, Nelms K, Paul WE and Ihle JN. . 1995 Mol. Cell Biol. 15: 3336–3343.

  • Roth M, Nauck M, Tamm M, . Perruchoud AP, Ziesche R and Block LH. . 1992 Proc. Natl. Acad. Sci. USA 92: 1312–1316.

  • Sadowski HB, Shuai K, Darnell Jr JE and Gilman MZ. . 1993 Science 261: 1739–1744.

  • Schindler C and Darnell Jr JE. . 1995 Ann. Rev. Biochem. 64: 621–651.

  • Shimoda K, Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DAA, Doherty PC, Grosveld G, Paul WE and Ihle JN. . 1996 Nature 380: 630–633.

  • Silvennoinen O, Schindler C, Schlessinger J and Levy DE. . 1993 Science 261: 1736–1739.

  • Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T and Akira S. . 1996 Nature 380: 627–630.

  • Takemura H, Suzuki H, Fujisawa H, Yuhara T, Akama T, Yamane K and Kashiwagi H. . 1998 J. Rheumatol. 25: 1534–1539.

  • Trautmann A, Krohne G, Brocker E-B and Klein CE. . 1998 J. Immunol. 160: 5053–5057.

  • Van der Meeren A, Seddon MB, Betsholtz CA, Lechner JF and Gerwin BI. . 1993 Am. J. Respir. Cell Mol. Biol. 8: 214–221.

  • Vignais M, Sadowski HB, Watling D, Rogers NC and Gilman M. . 1996 Mol. Cell. Biol. 16: 1759–1769.

  • Vignaud J-M, Marie B, Klein N, Plenat F, Pech M, Borrelly J, Martinet N, Duprez A and Martinet Y. . 1994 Cancer Res. 54: 5455–5463.

  • Wang L-M, Keegan AD, Paul WE, Heidaran MA, Gutkind JS and Pierce JH. . 1992 EMBO J. 11: 4899–4908.

  • Wang LM, Keegan AD, Li W, Lienhard GE, Pacini S, Gutkind JS, Myers MG, Sun XJ, White MF, Aaronson SA, Paul WE and Pierce JH. . 1993a Proc. Natl. Acad. Sci. USA 90: 4032–4036.

  • Wang LM, Myers MG, Sun XJ, Aaronson SA, White M and Pierce JH. . 1993b Science 261: 1591–1594.

  • Waterfield MD, Scrace GT, Whittle N, Stroobant P, Johnsson A, Westermark A, Heldin CH, Huang JS and Deuel TF. . 1983 Nature 304: 35–39.

  • Wigler M, Silverstein S, Lee S, Pellicer A, Cheng Y-C and Axel R. . 1977 Cell 11: 223–232.

  • Witthuhn BA, Silvennoinen O, Miura O, Lai KS, Cwik C, Liu ET and Ihle JN. . 1994 Nature 370: 153–157.

  • Zhong Z, Wen Z and Darnell Jr JE. . 1994 Science 264: 95–98.

Download references

Acknowledgements

We thank Drs Jackie Pierce, Stuart Rudikoff, Matt Lorenzi, Marcio Chedid, and Ling-Mei Wang for helpful discussions. We also acknowledge Nelson Ellmore and Veena Kapoor for valuable technical assistance. We thank Dr Stuart Rudikoff for providing the murine IL-6 cDNA probe and Dr Keith Peden for his generous gift of the SV40 large T antigen. MJ Grusby is a Scholar of the Leukemia Society of America and supported by NIH grant AI40171, as well as a gift from the Mathers Foundation.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kriebel, P., Patel, B., Nelson, S. et al. Consequences of Stat6 deletion on Sis/PDGF- and IL-4-induced proliferation and transcriptional activation in murine fibroblasts. Oncogene 18, 7294–7302 (1999). https://doi.org/10.1038/sj.onc.1203148

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203148

Keywords

This article is cited by

Search

Quick links